Sitemap

EU Expects First COVID Vaccine Application In Coming Days

More...

Government, Freelancers Associations Reach Agreement On Paying Taxes

Today, the government of the Republic of Serbia reached an agreement with the representatives of the Association of Freelancers...

EU Delegation and Council of Europe Office Welcome New Rules Aimed at Preventing Undue Influence on Judges and Prosecutors

The Serbian High Judicial Council (HJC) and the State Prosecutorial Council (SPC) have adopted on 15 and 19 April 2021...

The European Commission And Austria Secure COVID-19 Vaccines For The Western Balkans

The European Commission and Austria are announcing today the conclusion of agreements for the delivery of COVID-19 vaccines for...

Greece Removes Quarantine For Travellers From EU And Other Countries

Greece has lifted its quarantine requirement for travellers from the European Union provided they have been vaccinated or tested...

WHO Describes Immunisation Process In Serbia As Impressive

Prime Minister Ana Brnabic talked with World Health Organisation (WHO) Regional Director for Europe Hans Kluge about the epidemiological...

The European Medicines Agency did not name the company it expects to file the application. However, EU leaders hope a vaccine will be available before the end of the year.

The first application for marketing approval of a COVID-19 vaccine in the European Union should arrive in the next few days, according to the European Medicines Agency (EMA).

The drug watchdog did not identify the drugmaker expected to file, however partners Pfizer and BioNTEch are the most advanced in the regulatory approval process. A total of three drugmakers have published late-stage trial data for their respective coronavirus vaccine candidates, including US firm Moderna, and a British partnership between AstraZeneca and Oxford University.

The Pfizer-BioNTech collaboration has already applied for approval in the US, and the UK has asked its medical regulator to assess the vaccine.

Researchers on the US-German vaccine should enjoy a speedy approval process, as they have been allowed to submit data in real-time to the EMA, without waiting for studies to conclude.

The EMA earlier acknowledged it was trying “to speed up” the evaluation process, but said it was “ensuring the same high regulatory standards for quality, safety and efficacy” as for any other drug.

EMA told the AFP news agency that it could approve the first COVID-19 vaccines by the end of the year. Many European countries, including France, Spain and Italy, have based their immunization plans on that basis.

German Chancellor Angela Merkel told lawmakers Thursday that a vaccine may become available before the end of the year.

In the US, if the Food and Drug Administration (FDA) approves accelarated rollout, vaccination efforts may start as early as mid-December.

Related

US Pharma Firm Moderna Says Its COVID-19 Vaccine Is 94.5% Effective

Moderna said that Phase 3 stage analysis suggested its coronavirus vaccine could prevent COVID-19. The news comes a week after Pfizer and German drug-maker...

Oxford Covid Vaccine Works In All Ages, Trials Suggest

Covid vaccine being trialled by Oxford University and AstraZeneca offers hope for all age groups One of the world’s leading Covid-19 experimental vaccines produces an...

Vaccination rollout

In China, medical authorities have already begun immunizing high-risk patients. In Russia, two vaccines have been validated for use before the final phase of clinical trials had started.

The candidates that have passed trials all claim more than 90% effiacy, but their results have not yet been backed up by by publication in peer-reviewed journals, which can usually take months.

Price and logistics will also factor in the success of the vaccines. AstraZeneca’s double dose is the cheapest, costing about €2.5 ($3) per dose and requires just a normal fridge temperature. Moderna’s vaccine must be kept at -20 degrees Celsius (-4 Farenheit), while Pfizer’s must be kept at -70C (-94 Farenheit).

Source:  Deutsche Welle

Related Articles

The European Commission And Austria Secure COVID-19 Vaccines For The Western Balkans

The European Commission and Austria are announcing today the conclusion of agreements for the delivery of COVID-19 vaccines for the Western Balkans. The 651,000...

Greece Removes Quarantine For Travellers From EU And Other Countries

Greece has lifted its quarantine requirement for travellers from the European Union provided they have been vaccinated or tested negative for COVID-19 over the...

The First Conference On The Air Protection Programme In Serbia

The first conference on preparing the Draft of the Air Protection Programme in the Republic of Serbia with accompanying Action plan was held. The programme is...

Production Of Sputnik V Launched In Serbia

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) and Institute of Virology, Vaccines and Sera “Torlak” announce the launch of production of...

Distribution Of Laptops And Tablets, Bridging Digital Divide In Serbia For The Most Vulnerable Children Project

The Head of the European Union Delegation to Serbia, Ambassador Sem Fabrizi, UNICEF Representative in Serbia, Deyana Kostadinova, and Ivica Rakovic, State Secretary in...

Vaccine Passports Are Sreading Across The World Here’s How They Could Work In The US

Vaccine passports are set to become a part of everyday life right across the world as governments race to vaccinate their populations against the...

Skopje Launches Mass Coronavirus Vaccination With Russia’s Sputnik V

Vaccines are available for police officers, Interior Ministry employees, pharmacists, pre-school and school teachers as well as other categories qualified as a critical group Mass...

Serbian Torlak Institute To Get Technology For Sputnik V Vaccine

Serbia’s Torlak Institute on Monday signed a technology transfer agreement with the Russian Direct Investment Fund and the Russian pharmaceuticals company Generium under which...